| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |